Entering text into the input field will update the search result below

TherapeuticsMD settles U.S. patent litigation with Amneal for Bijuva

Business woman signs a patent. Intellectual property protection concept. Patent attorney.

Irina Vodneva/iStock via Getty Images

  • TherapeuticsMD (NASDAQ:TXMD) announces the settlement of the previously disclosed U.S. patent litigation for Bijuva with Amneal Pharmaceuticals (NYSE:AMRX).
  • TXMD shares up 2% premarket at $0.45.
  • As part of the settlement, TXMD granted to Amneal a license to

Recommended For You

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.